2023

"Allgens Synthetic bone graft material project" capacity transfer, officially put into production, production capacity will be greatly doubled, fully help the company's capacity release.
Allgens Medical Selected as National Specialized Special New "Little Giant" Enterprise

2022

The new leadership team of Allgens Medical has been established, and Cui Menglong is the general manager of the company, creating a new situation of high-speed and high-quality development of the company.
Allgens Medical on the List of Beijing Specialized New "Little Giant" Enterprises
Tsinghua University (School of Materials Science and Technology)-Allgens Medical Technology Co., Ltd. Regenerative Medicine Materials Joint Research Center was inaugurated and launched

2021

Allgens Medical's initial public offering and successful listing on the board.

2020

Access to the Ministry of Science and Technology "13th Five-Year" key R & D plan project support

2019

Allgens International Health Science and Technology Industrial Park held a grand capping ceremony in Fangzi District and held an international academic seminar on regenerative medicine materials.
The research project of Weifang Allgens Medical Research Co., Ltd. was supported by the key research and development plan of Shandong Province.
Allgens Company Approved by Beijing Science and Technology Association to Set up Academician Expert Workstation
Allgens company completed the shareholding system reform, "Allgens Medical Technology Co., Ltd." was formally established.
CPC Allgens Medical Technology Co., Ltd. Party Branch Committee Formally Established
Allgens Health Science and Technology Industrial Park was successfully completed and accepted, and the real estate certificate was processed in time.
Shandong Allgens was approved by the Department of Science and Technology of Shandong Province to set up an academician expert workstation.

2018

Ao Sperm Company Shandong Allgens Biotechnology Co., Ltd. was established in Weifang City, Shandong Province
The headquarters building of Allgens Company was completed and officially opened, opening a new journey of Allgens development.
The foundation laying ceremony of Allgens International Health Science and Technology Industrial Park and the unveiling ceremony of Weifang Allgens International Research Institute of Regenerative Medical Materials were held in Fangzi District of Weifang City
The artificial bone repair material "BONGOLD®" was selected into the "Innovative Medical Device Product Catalog (2018)" of the Ministry of Science and Technology of China, and became the only implantable medical device product in the field of orthopedics that was recognized as "international original".
"Allgens Health Science and Technology Industrial Park" project was selected as the preferred project of Shandong Province's new and old kinetic energy transformation major project library.

2017

Beijing Allgens signed a strategic cooperation agreement with the people's Government of Fangzi District of Weifang City to build Allgens Health Science and Technology Industrial Park.

2016

Selected Beijing Biopharmaceutical Industry Leapfrog Development Project (G20 Project) Innovation Leading Enterprise

2015

Synthetic bone graft material have obtained the US FDA 510(k) market access license, which is the first domestic Synthetic bone product approved by the US FDA in China.

2014

Synthetic bone graft material have obtained three types of medical device product registration certificates in the fields of stomatology, plastic surgery and neurosurgery.

2011

Synthetic bone repair material "BONGOLD®" to obtain Class Ill of medical device product registration certificate
Supported by the Ministry of Science and Technology "Twelfth Five-Year" National Science and Technology Support Program
Professor Cui Fuzhai, chief scientific adviser, won the second prize of National Natural Science Award (the first prize winner, the first prize vacancy) and was received by then President Hu Jintao

2008

Obtain the first invention patent
Professor Cui Fuzhai, Chief Scientific Advisor, won the second prize of National Technological Invention Award (the first winner)

2007

Supported by the National High Technology Research and Development Program (863 Program)
Supported by the "Eleventh Five-Year" National Science and Technology Support Program of the Ministry of Science and Technology

2005

The first ten thousand grade clean workshop was completed and the medical equipment production license was obtained.

2004

On December 22, 2004, Beijing Allgens Pharmaceutical Technology Co., Ltd. was established in Zhongguancun Biomedical Park.